These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm. Pennathur A; Luketich JD; Landreneau RJ; Ward J; Christie NA; Gibson MK; Schuchert M; Cooper K; Land SR; Belani CP Ann Thorac Surg; 2008 Jun; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797 [TBL] [Abstract][Full Text] [Related]
8. Downstaging of T or N predicts long-term survival after preoperative chemotherapy and radical resection for esophageal carcinoma. Korst RJ; Kansler AL; Port JL; Lee PC; Kerem Y; Altorki NK Ann Thorac Surg; 2006 Aug; 82(2):480-4; discussion 484-5. PubMed ID: 16863749 [TBL] [Abstract][Full Text] [Related]
9. Correlation of molecular response as measured by 18-FDG positron emission tomography with outcome after chemoradiotherapy in patients with esophageal carcinoma. Konski AA; Cheng JD; Goldberg M; Li T; Maurer A; Yu JQ; Haluszka O; Scott W; Meropol NJ; Cohen SJ; Freedman G; Weiner LM Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):358-63. PubMed ID: 17532577 [TBL] [Abstract][Full Text] [Related]
10. Assessment of treatment response and recurrence in esophageal carcinoma based on tumor length and standardized uptake value on positron emission tomography-computed tomography. Roedl JB; Harisinghani MG; Colen RR; Fischman AJ; Blake MA; Mathisen DJ; Mueller PR Ann Thorac Surg; 2008 Oct; 86(4):1131-8. PubMed ID: 18805147 [TBL] [Abstract][Full Text] [Related]
11. Value of complete metabolic response by (18)F-fluorodeoxyglucose-positron emission tomography in oesophageal cancer for prediction of pathologic response and survival after preoperative chemoradiotherapy. Kim MK; Ryu JS; Kim SB; Ahn JH; Kim SY; Park SI; Kim YH; Song HY; Shin JH; Jung HY; Lee GH; Choi KD; Cho KJ; Kim JH Eur J Cancer; 2007 Jun; 43(9):1385-91. PubMed ID: 17512192 [TBL] [Abstract][Full Text] [Related]
15. Positron-Emission Tomography Scan-Directed Chemoradiation for Esophageal Squamous Cell Carcinoma: No Benefit for a Change in Chemotherapy in Positron-Emission Tomography Nonresponders. Greally M; Chou JF; Molena D; Rusch VW; Bains MS; Park BJ; Wu AJ; Goodman KA; Kelsen DP; Janjigian YY; Ilson DH; Ku GY J Thorac Oncol; 2019 Mar; 14(3):540-546. PubMed ID: 30391577 [TBL] [Abstract][Full Text] [Related]
16. [Preoperative chemoradiation in esophageal cancer: experience of a single center in 102 patients]. Imdahl A; Schöffel U; Ruf G; Hopf UT Zentralbl Chir; 2004 Oct; 129(5):350-5. PubMed ID: 15486784 [TBL] [Abstract][Full Text] [Related]
17. Predictive value of 18-fluoro-deoxy-glucose-positron emission tomography (18F-FDG-PET) in the identification of responders to chemoradiation therapy for the treatment of locally advanced esophageal cancer. Levine EA; Farmer MR; Clark P; Mishra G; Ho C; Geisinger KR; Melin SA; Lovato J; Oaks T; Blackstock AW Ann Surg; 2006 Apr; 243(4):472-8. PubMed ID: 16552197 [TBL] [Abstract][Full Text] [Related]